Moneycontrol » News » Business » Business News

Aurobindo receives 36th USFDA approval

Published on Fri, Jan 19, 2007 at 19:55 |  Source : Moneycontrol.com

Updated at Fri, Jan 19, 2007 at 20:09  

16108 Investors following Aurobindo Pharm. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

ALSO READ

Aurobindo Pharm

BSE | NSE 25/05/12

Aurobindo Pharma Limited is pleased to announce that the company has received one more approval from the US FDA for Amoxicillin Tablets For oral suspension 200mg and 400mg.

 

Amoxicillin Tablets for oral suspension is a Beta-lactam antibiotic used often in treating respiratory infections. With this approval Aurobindo has its Amoxicillin approved by USFDA in four different formulations.

 

Sourced From: Aurobindo Pharma Limited

  

PREVIOUS STORY

Buy TVS Motor; target Rs 43: Dolat Capital

NEXT STORY

How credit card companies are making a comeback

Trending News

Business News

Tags: Aurobindo Pharma , US FDA , Amoxicillin Tablets , Beta-lactam , oral suspension , respiratory infections, approval
Indian PC market growth sluggish in Q1; Lenovo tops the list
Nifty level to watch is 5,150; Bank Index upside is modest "Nifty level to watch is 5,150; Bank Index upside is modest "

News

Sourav Ganguly tips KKR to win IPL 5

The former India skipper also rated Gautam Gambhir ahead of Mahendra Singh Dhoni as far as captaincy
Army is in a much better state today: Gen VK Singh
Oil price rollback will hurt India badly: Basu
Won't allow Pak to become 'Indian market': Saeed
CBSE marks cannot be given under RTI: HC
India, Myanmar to explore new initiatives: PM
Team Anna welcomes Krishna's defamation suit
Govt is trying to malign me: Jagan
Germany sets new solar power record
Indian boy solves 350-year-old Math problem
SC upholds conviction of duo for Rs 100 bribe
3 mountaineers from Jharkhand scale Mt Everest
Over 90 killed including 32 children in Syria: UN
The dream team of IPL 5
'Dhoni needs to work on his Test batting'
Nadal clouds Djokovic's bid to match Laver
Sharapova, Serena head to Paris as favourites
Preview: Fourth episode of 'Satyamev Jayate'
'Rowdy Rathore' Akshay Kumar too busy for TV
Masand: 'Arjun: The Warrior...' is a valiant effort
Masand: 'Men in Black 3' offers super special effects
Review: 'Yeh Khula Aasmaan' is heartwarming
Review: 'The Grey' is a spellbinding tale
Telugu Review: 'Daruvu' is noisy and lost in chaos
Nokia 808 PureView up for pre-order for Rs 32,000
Review: Solmate Flare portable solar charger
Reputed govt, pvt websites under hacker threat
KTM 200 Duke vs Yamaha R15 v2.0 vs CBR250R
Hodgson starts England reign with Norway win
Germany stunned by Switzerland in Euro warm-up
Spain beat Serbia 2-0 in Euro 2012 warm-up
Netherlands lost 2-1 to Bulgaria in friendly

Rel Comm Q4 Cons Net Revenue Up 5% At `5,310 Cr (QoQ)

The latest earning numbers FIRST on CNBC-TV18
Videos

May 26 2012, 16:36

Mood downbeat but time to buy good values now: Citi`s Vaish

- in FII View

May 25 2012, 22:26

NHPC posts profit amid capacity addition, delay woes

- in Results Boardroom

Interviews

May 25 2012, 22:00 | Source: CNBC-TV18

Petrol hike on soft global levels is short-sighted: Narayan  

May 25 2012, 17:05 | Source: CNBC-TV18

Expect single digit growth in ad revenue in FY13: Sun TV  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window